rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-4-13
|
pubmed:abstractText |
Human leukocyte antigen G (HLA-G) molecules exhibit immunomodulatory properties corresponding to nonclassic class I genes of the major histocompatibility complex. They are either membrane-bound or solubly expressed during certain tumoral malignancies. Soluble human leukocyte antigen G (sHLA-G) molecules seem more frequently expressed than membrane-bound isoforms during hematologic malignancies, such as lymphoproliferative disorders. Assay of these molecules by enzyme-linked immunosorbent assay in patients suffering from another hematologic disorder (acute leukemia) highlights increased sHLA-G secretion. This increased secretion seems more marked in acute leukemia subtypes affecting monocytic and lymphoid lineages such as FABM4 and FABM5, as well as both B and T acute lymphoblastic leukemia (ALL). Moreover, this study uses in vitro cytokine stimulations and reveals the respective potential roles of granulocyte-macrophage colony-stimulating factor and interferon-gamma in increasing this secretion in FABM4 and ALL. Correlations between sHLA-G plasma level and clinical biologic features suggest a link between elevated sHLA-G level and 1) the absence of anterior myelodysplasia and 2) high-level leukocytosis. All these findings suggest that sHLA-G molecules could be a factor in tumoral escape from immune survey during acute leukemia.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-10082427,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-10330285,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-10429764,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-10479047,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-10843658,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11026456,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11087747,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11091213,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11137213,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11137219,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11163092,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11466692,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11549573,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11559559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11572934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11781245,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11857488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-11971028,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12438449,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12516543,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12552087,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12594841,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12681364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12878353,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-12878359,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14555519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14602230,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14602240,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14697234,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14708714,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14708718,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-14737978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-1570318,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-16214086,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-16216668,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-2326636,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-3480534,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-7989753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-8181068,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-8183892,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-8988550,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9144223,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9221758,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9326642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9464826,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9539768,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9645380,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9712358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16611416-9933109
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1476-5586
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
223-30
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16611416-Humans,
pubmed-meshheading:16611416-Leukemia, Myeloid,
pubmed-meshheading:16611416-Leukemia,
pubmed-meshheading:16611416-Acute Disease,
pubmed-meshheading:16611416-Retrospective Studies,
pubmed-meshheading:16611416-Burkitt Lymphoma,
pubmed-meshheading:16611416-Solubility,
pubmed-meshheading:16611416-Antigens, Neoplasm,
pubmed-meshheading:16611416-Tumor Markers, Biological,
pubmed-meshheading:16611416-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:16611416-Cell Line, Tumor,
pubmed-meshheading:16611416-HLA Antigens
|